Patients are at the center of everything that we do at United Therapeutics. It was founded because of a patient with PAH. Everyone that works at United Therapeutics recognizes that this is at the core of what we do and are really proud of that.
Patient Organizations
United Therapeutics Corporation engages with patient advocacy organizations, professional organizations, and foundations to better understand and help meet the needs of patients, caregivers, and others in the rare disease community.
We provide charitable support and educational grants to these organizations to help support their development and sustainment of resources for the patient and HCP community.
Phaware Global Association
phaware® creates pulmonary hypertension awareness and global engagement on behalf of families, caregivers, and medical professionals affected by PAH and supports innovative research efforts to help find a cure.
Team PHenomenal Hope
Team PHenomenal Hope seeks to raise awareness of Pulmonary Hypertension, fund medical research into improved treatments or a cure for those who suffer from it, and to implement programming that focuses on providing patient services, including removing patients from isolation, building community, and providing hope.
Pulmonary Fibrosis Foundation (PFF)
The mission of the Pulmonary Fibrosis Foundation is to accelerate the development of new treatments and ultimately a cure for pulmonary fibrosis.
Pulmonary Hypertension Association of Canada
PHA Canada supports PH patients and their families through programming, and funds research in hope of one day finding a cure.
Scleroderma Foundation
Scleroderma is a chronic connective tissue disease. Patients with scleroderma are at high risk of getting PAH. The Scleroderma Foundation supports patients and their families through support programs, peer counseling, raising public awareness, and stimulating research to improve treatment.
EveryLife Foundation
The EveryLife Foundation for Rare Diseases is dedicated to empowering the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments and cures.
Pulmonary Hypertension Association
PHA envisions a world without pulmonary hypertension. This organization is dedicated to improving the lives of everyone affected by pulmonary hypertension. Through support, advocacy, awareness, education, and research programs, PHA empowers patients, caregivers, families, healthcare providers, and researchers worldwide.
